CRSP Crispr Therapeutics AG

Fundamentals / CIK 0001674416 / USD

Crispr Therapeutics AG reported $25.17M in revenue and a net loss of $456.1M for the trailing twelve months ended September 30, 2026 (up 1325.1% year over year), with a -2114.8% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CRSP in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$970.4M$485.2M$0-$685.7MFY 2016 Revenue: $5.16MFY 2016 Net Income: -$23.18M2016FY 2017 Revenue: $41.00MFY 2017 Net Income: -$68.36M2017FY 2018 Revenue: $3.12MFY 2018 Net Income: -$165.0M2018FY 2019 Revenue: $289.6MFY 2019 Net Income: $66.86M2019FY 2020 Revenue: $719KFY 2020 Net Income: -$348.9M2020FY 2021 Revenue: $915.0MFY 2021 Net Income: $377.7M2021FY 2022 Revenue: $1.20MFY 2022 Net Income: -$650.2M2022FY 2023 Revenue: $371.2MFY 2023 Net Income: -$153.6M2023FY 2024 Revenue: $37.31MFY 2024 Net Income: -$366.3M2024FY 2025 Revenue: $3.51MFY 2025 Net Income: -$581.6M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $3.51M $37.31M $371.2M $1.20M $915.0M $719K $289.6M $3.12M $41.00M $5.16M
Research & Development $284.8M $310.2M $387.3M $461.6M $340.6M $221.4M $179.4M $113.8M $69.80M $42.24M
Total Operating Expenses $668.1M $503.9M $593.7M $674.4M $541.4M $355.2M $242.8M $162.1M $105.6M $73.29M
Operating Income -$664.6M -$466.6M -$222.5M -$673.2M $373.5M -$354.4M $46.74M -$158.9M -$64.65M -$68.13M
EBITDA -$645.1M -$447.3M -$202.7M -$649.0M $391.5M -$345.3M $51.47M -$155.4M -$61.62M -$67.20M
Interest Income -- $104.3M $76.40M $23.30M -- -- -- -- -- --
Income Before Tax -$578.0M -$362.7M -$150.7M -$650.5M $379.5M -$348.1M $67.31M -$164.4M -$66.61M -$22.72M
Income Tax Expense $3.63M $3.59M $2.89M -$325K $1.87M $809K $448K $553K $1.75M $484K
Net Income -$581.6M -$366.3M -$153.6M -$650.2M $377.7M -$348.9M $66.86M -$165.0M -$68.36M -$23.18M
Basic EPS -$6.47 -$4.34 -$1.94 -$8.36 $4.97 -$5.29 $1.23 -$3.44 -$1.71 -$1.89
Diluted EPS -$6.47 -$4.34 -$1.94 -$8.36 $4.70 -$5.29 $1.17 -$3.44 -$1.71 -$1.89
Basic Shares Outstanding 89.9M 84.4M 79.2M 77.7M 75.9M 65.9M 54.4M 48.0M 40.1M 12.3M
Diluted Shares Outstanding 89.9M 84.4M 79.2M 77.7M 80.4M 65.9M 56.9M 48.0M 40.1M 12.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $12.67M $10.18M $1.46M $864K $889K $892K $865K $35.69M
Research & Development $71.89M $67.15M $68.57M $83.53M $58.90M $69.89M $72.48M $71.74M
Total Operating Expenses $142.7M $127.5M $131.7M $155.6M $132.9M $230.2M $149.3M $100.3M
Operating Income -$130.0M -$117.3M -$130.2M -$154.8M -$132.1M -$229.3M -$148.4M -$64.59M
EBITDA -$125.8M -$113.0M -$125.9M -$149.1M -$127.6M -$224.7M -$143.7M -$59.75M
Interest Expense $3.33M $3.32M $553K -- $0 $0 $0 --
Income Before Tax -$111.4M -$90.19M -$122.1M -$130.0M -$105.8M -$207.3M -$134.9M -$36.61M
Income Tax Expense $74K $960K $839K $614K $619K $1.29M $1.11M $700K
Net Income -$111.4M -$91.15M -$122.9M -$130.6M -$106.4M -$208.5M -$136.0M -$37.31M
Basic EPS -$1.15 -$0.94 -$1.28 -- -$1.17 -$2.40 -$1.58 --
Diluted EPS -$1.15 -$0.94 -$1.28 -- -$1.17 -$2.40 -$1.58 --
Basic Shares Outstanding 96.7M 96.5M 96.1M -- 91.3M 87.1M 85.9M --
Diluted Shares Outstanding 96.7M 96.5M 96.1M -- 91.3M 87.1M 85.9M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $347.6M $298.3M $389.5M $211.9M $923.0M $1.17B $943.8M $456.6M $239.8M $315.5M
Short-Term Investments $1.63B $1.61B $1.30B $1.60B $1.46B $521.7M $0 -- -- --
Cash & Short-Term Investments $1.98B $1.90B $1.69B $1.82B $2.38B $1.69B $943.8M $456.6M $239.8M $315.5M
Accounts Receivable, Net $0 $25.00M $200.0M $0 $305K $144K $99K $88K $2.63M $3.16M
Total Current Assets $1.99B $1.94B $1.91B $1.85B $2.42B $1.72B $987.5M $466.4M $248.4M $320.2M
Property, Plant & Equipment, Net $115.9M $134.1M $151.9M $163.6M $137.6M $42.16M $31.33M $18.50M $18.86M $21.03M
Intangible Assets -- $0 $16K $71K $125K $180K $235K $289K $344K $399K
Long-Term Investments $0 $0 $1.97M $53.13M $0 -- -- -- -- --
Other Non-Current Assets $24.37M $15.83M $1.98M $4.64M $5.29M $1.29M $1.10M $669K $606K $198K
Total Non-Current Assets $279.6M $304.9M $321.5M $390.0M $334.4M $111.3M $79.20M $22.62M $22.96M $24.77M
Total Assets $2.27B $2.24B $2.23B $2.24B $2.75B $1.83B $1.07B $489.0M $271.3M $345.0M
Accounts Payable $11.14M $14.71M $38.15M $27.43M $14.82M $9.09M $5.94M $5.07M $1.64M $4.57M
Deferred Revenue (Current) $15.77M $3.85M $4.11M $0 $1.01M $2.34M $960K $102K -- --
Other Current Liabilities $13.11M $10.42M $5.14M $20K $171K $7.21M $10.95M $119K $137K $59K
Total Current Liabilities $149.1M $87.78M $108.8M $121.1M $119.9M $94.26M $57.11M $27.75M $14.51M $22.00M
Long-Term Debt $0 -- -- -- -- -- -- -- -- --
Deferred Revenue (Non-Current) $0 $12.32M $14.01M $12.32M $12.32M $11.78M $11.78M $57.78M $56.93M $77.65M
Other Non-Current Liabilities $6.14M $3.44M $958K $5.97M $7.34M $7.63M $14.39M $243K $314K $189K
Total Non-Current Liabilities $194.3M $222.2M $238.0M $246.5M $232.5M $69.47M $70.22M $69.08M $69.00M $90.12M
Total Liabilities $343.4M $310.0M $346.8M $367.6M $352.4M $163.7M $127.3M $96.82M $83.51M $112.1M
Total Debt (incl. Leases) $206.7M $223.7M $238.6M $244.0M $225.0M $61.43M $52.54M -- -- --
Common Stock $3.09M $2.70M $2.50M $2.44M $2.39M $2.28M $1.85M $1.58M $1.24M $1.22M
Retained Earnings -$1.95B -$1.37B -$999.7M -$846.1M -$195.9M -$573.6M -$224.7M -$291.6M -$125.4M -$57.08M
Accumulated Other Comp. Income $4.82M $1.84M $1.91M -$15.65M -$5.07M -$83K $7.0K -$8.0K $14K -$26K
Total Stockholders' Equity $1.92B $1.93B $1.88B $1.88B $2.40B $1.66B $939.4M $392.2M $187.8M $232.8M
Total Equity $1.92B $1.93B $1.88B $1.88B $2.40B $1.66B $939.4M $392.2M $187.8M $232.8M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $192.0M $291.3M $423.3M $347.6M $286.5M $193.6M $235.2M $298.3M
Short-Term Investments $2.08B $2.07B $2.02B $1.63B $1.63B $1.53B $1.62B $1.61B
Cash & Short-Term Investments $2.27B $2.36B $2.44B $1.98B $1.92B $1.72B $1.86B $1.90B
Accounts Receivable, Net -- -- -- $0 $0 $0 $0 $25.00M
Total Current Assets $2.29B $2.37B $2.45B $1.99B $1.93B $1.73B $1.87B $1.94B
Property, Plant & Equipment, Net $104.3M $108.1M $112.2M $115.9M $120.8M $124.9M $129.4M $134.1M
Intangible Assets -- -- -- -- -- -- -- $0
Long-Term Investments $4.02M $0 $0 $0 $28.41M $0 $0 $0
Other Non-Current Assets $32.78M $37.71M $28.98M $24.37M $24.31M $25.47M $20.78M $15.83M
Total Non-Current Assets $271.3M $279.0M $277.5M $279.6M $316.2M $296.0M $298.5M $304.9M
Total Assets $2.56B $2.65B $2.73B $2.27B $2.25B $2.03B $2.17B $2.24B
Accounts Payable $20.59M $11.31M $13.65M $11.14M $11.80M $9.75M $13.06M $14.71M
Deferred Revenue (Current) $2.55M $15.19M $15.34M $15.77M $1.29M $2.13M $3.02M $3.85M
Other Current Liabilities $17.00M $16.98M $13.11M $13.11M $0 $0 $0 $10.42M
Total Current Liabilities $141.0M $132.9M $136.3M $149.1M $119.0M $104.4M $119.4M $87.78M
Long-Term Debt $586.9M $586.2M $585.5M $0 -- -- -- --
Deferred Revenue (Non-Current) -- -- -- $0 $12.32M $12.32M $12.32M $12.32M
Other Non-Current Liabilities $6.24M $6.22M $5.95M $6.14M $5.28M $4.48M $3.32M $3.44M
Total Non-Current Liabilities $767.4M $771.3M $775.0M $194.3M $210.4M $214.2M $217.5M $222.2M
Total Liabilities $908.3M $904.2M $911.3M $343.4M $329.3M $318.6M $336.9M $310.0M
Total Debt (incl. Leases) $779.8M $783.7M $787.6M $206.7M $211.0M $215.5M $219.4M $223.7M
Common Stock $3.15M $3.13M $3.12M $3.09M $3.01M $2.79M $2.72M $2.70M
Retained Earnings -$2.27B -$2.16B -$2.07B -$1.95B -$1.82B -$1.71B -$1.50B -$1.37B
Accumulated Other Comp. Income -$14.08M -$4.63M -$1.94M $4.82M $4.99M $4.04M $4.13M $1.84M
Total Stockholders' Equity $1.65B $1.75B $1.81B $1.92B $1.92B $1.71B $1.83B $1.93B
Total Equity $1.65B $1.75B $1.81B $1.92B $1.92B $1.71B $1.83B $1.93B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$581.6M -$366.3M -$153.6M -$650.2M $377.7M -$348.9M $66.86M -$165.0M -$68.36M -$23.20M
Depreciation & Amortization $19.48M $19.26M $19.84M $24.17M $17.95M $9.18M $4.72M $3.52M $3.02M $925K
Stock-Based Compensation $72.50M $86.57M $81.03M $97.95M $102.4M $66.02M $44.06M $34.98M $18.87M $10.84M
Change in Receivables $25.00M $175.0M -$200.0M $305K -$161K -$45K -$11K $2.54M $531K -$2.82M
Operating Cash Flow -$345.0M -$142.8M -$260.4M -$495.7M $539.0M -$238.4M $56.68M -$96.24M -$70.09M -$52.86M
Capital Expenditure -$914K -$1.90M -$9.47M -$37.19M -$81.70M -$18.36M -$6.68M -$2.77M -$7.81M -$3.02M
Free Cash Flow -$345.9M -$144.7M -$269.8M -$532.9M $457.3M -$256.7M $49.99M -$99.01M -$77.91M -$55.88M
Purchases of Investments -$1.01B -$1.46B -$1.07B -$1.42B -$1.51B -$594.0M -- -- -$500K --
Investing Cash Flow -$31.80M -$280.5M $374.6M -$258.7M -$1.04B -$541.2M $1.32M -$2.77M -$8.31M $31.88M
Common Stock Issued $398.1M $300.7M $32.72M $970K $213.3M $982.3M $415.0M $307.1M $0 $89.06M
Share Repurchases -- -- -- -- -- -- -- -$57K -- --
Financing Cash Flow $426.0M $332.0M $62.66M $38.59M $250.9M $1.02B $431.0M $315.9M $2.61M $183.2M
Net Change in Cash $49.30M -$91.29M $177.0M -$715.9M -$245.5M $236.7M $489.0M $216.9M -$75.76M $162.0M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$111.4M -$91.15M -$122.9M -$130.6M -$106.4M -$208.5M -$136.0M -$37.31M
Depreciation & Amortization $4.24M $4.28M $4.32M $5.66M $4.43M $4.65M $4.74M $4.84M
Stock-Based Compensation $17.96M $17.32M $16.32M $18.08M $16.60M $17.61M $20.21M $21.95M
Change in Receivables $0 $0 $0 $0 $0 $0 $25.00M -$25.00M
Operating Cash Flow -$89.68M -$83.50M -$108.9M -$92.55M -$84.63M -$113.9M -$53.95M -$50.03M
Capital Expenditure -$414K -$648K -$504K -$517K -$74K -$117K -$206K -$254K
Free Cash Flow -$90.10M -$84.15M -$109.4M -$93.07M -$84.71M -$114.0M -$54.15M -$50.28M
Purchases of Investments -$321.3M -$206.3M -$746.1M -$263.0M -$334.1M -$210.4M -$200.7M -$264.1M
Investing Cash Flow -$14.09M -$55.66M -$410.7M $37.20M -$119.2M $69.98M -$19.75M $105.8M
Common Stock Issued $0 $0 -$722K $111.5M $278.1M -$22K $8.52M $14.96M
Financing Cash Flow $4.45M $7.18M $591.9M $116.4M $296.8M $2.26M $10.59M $16.88M
Net Change in Cash -$99.31M -$132.0M $72.24M $61.06M $92.88M -$41.56M -$63.07M $72.59M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -18933.6% -1250.4% -60.0% -56190.4% 40.8% -49295.5% 16.1% -5087.8% -157.7% -1319.3%
Net Profit Margin -16569.8% -981.5% -41.4% -54271.7% 41.3% -48520.9% 23.1% -5281.1% -166.7% -448.8%
Return on Equity (ROE) -30.3% -19.0% -8.2% -34.7% 15.7% -21.0% 7.1% -42.1% -36.4% -10.0%
Return on Assets (ROA) -25.7% -16.3% -6.9% -29.0% 13.7% -19.1% 6.3% -33.7% -25.2% -6.7%
Current Ratio 13.32x 22.07x 17.54x 15.30x 20.17x 18.21x 17.29x 16.81x 17.12x 14.56x
Quick Ratio 13.25x 21.97x 17.41x 14.99x 19.85x 17.93x 16.53x 16.46x 16.70x 14.49x
Debt to Equity 0.11x 0.12x 0.13x 0.13x 0.09x 0.04x 0.06x -- -- --
Revenue Growth (YoY) -90.6% -89.9% +30885.5% -99.9% +127154.9% -99.8% +9169.8% -92.4% +693.9% +1990.7%
Operating Income Growth (YoY) -- -- -- -280.2% -- -858.3% -- -- -- --
Net Income Growth (YoY) -- -- -- -272.2% -- -621.8% -- -- -- --
EPS Growth (YoY) -- -- -- -268.2% -- -530.1% -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -192.0% -- -520.6% -- -- -- -188.9%
Free Cash Flow Growth (YoY) -- -- -- -216.5% -- -613.5% -- -- -- -195.9%
5Y Revenue / Share Growth +258.0% -91.7% +7094.2% -98.5% +2759.6% -77.8% -- -- -- --
10Y Revenue / Share Growth -20.4% -- -- -- -- -- -- -- -- --
5Y Net Income / Share Growth -- -453.2% -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -2114.8% -3990.0% -15754.2% -18933.6% -1498.3% -1451.9% -1259.2% -1250.4%
Net Profit Margin -1812.1% -3368.7% -13856.5% -16569.8% -1273.7% -1229.4% -1023.6% -981.5%
Return on Equity (ROE) -27.7% -25.8% -31.3% -30.3% -25.5% -27.3% -21.1% -19.0%
Return on Assets (ROA) -17.8% -17.0% -20.9% -25.7% -21.7% -23.0% -17.8% -16.3%
Current Ratio 16.21x 17.85x 17.96x 13.32x 16.22x 16.61x 15.64x 22.07x
Quick Ratio 16.12x 17.79x 17.92x 13.25x 16.10x 16.49x 15.53x 21.97x
Debt to Equity 0.47x 0.45x 0.43x 0.11x 0.11x 0.13x 0.12x 0.12x
Revenue Growth (YoY) +1325.1% +1041.4% +68.6% -97.6% +47.7% +72.5% +71.6% -82.3%
Operating Income Growth (YoY) -- -- -- -- -- -- -- -192.8%
Net Income Growth (YoY) -- -- -- -- -- -- -- -141.8%
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -149.2% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -149.7% --
Source: SEC EDGAR CompanyFacts (CIK 0001674416) · from December 31, 2014 Data through September 30, 2026 · synced Nov 20, 2026, 05:17 UTC · Open in terminal